Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chaperonin containing TCP1 subunit 6 pseudogene 2 (CCT6P2) is a pseudogene and does not code for a functional protein product[1][2][3]. It is related by sequence homology to genes encoding subunits of the Chaperonin containing TCP1 (CCT), also known as the TCP1 ring complex (TRiC), which is a molecular chaperone complex involved in folding newly synthesized proteins such as actin and tubulin[5][6][7]. However, unlike functional subunits like CCT6A or CCT6B, CCT6P2 represents a non-functional remnant—a product of duplicated or inactivated gene copy that has lost protein-coding ability and is not known to have biological functions, disease associations, or value as a therapeutic target[1][2][3]. No drugs are known to interact with this pseudogene, and it is not used as a biomarker or subject to safety concerns. Key clarifications: - CCT6P2 is incorrectly listed as a therapeutic or direct biological target because it is a pseudogene and not a functional chaperonin subunit[1][2][3]. - The functional CCT6A and CCT6B genes have roles in protein folding and disease, but these do not apply to CCT6P2[4][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chaperonin containing TCP1 subunit 6 pseudogene 2 (CCT6P2).